Abeona Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Ohio, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
6555 Carnegie Ave Fl 4, Cleveland, Ohio,...Phone Number
(646) 813-4701Website
www.abeonatherapeutics.comRevenue
$14.5 MillionStock Symbol
ABEOIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Abeona Therapeutics
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on the research, development, manufacturing, and commercialization of advanced cell and gene therapies for serious diseases with significant unmet medical needs. The company is dedicated to developing innovative treatment approaches that address the underlying causes of rare and complex disorders rather than only managing symptoms.Explore more
Abeona Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Abeona Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Abeona Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Abeona Therapeutics
Check if Abeona Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Abeona Therapeutics had a recent Job posting/layoffs
Abeona Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Abeona Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Abeona Therapeutics has new funding data
Product Launch: Get notified when Abeona Therapeutics launches new products
Recommended Actions
Find VP level buyers at Abeona Therapeutics
Find 3 more new buyers
Compare Similar Companies to Abeona Therapeutics
Compare insights from companies similar to Abeona Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Abeona Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Abeona Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abeona Therapeutics.
Abeona Therapeutics financials insights
Gather financial insights about Abeona Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Other Financing Round
$3.6M
2015
Share Placement
$8.5M
2017
Grant
$13.8M
Share Placement
$92M
2019
Stock Offering
$103.5M
2020
Debt
$1M
2022
Other Financing Round
$35M
2023
Share Placement
$25M
Abeona Therapeutics Tech Stack
A closer look at the technologies used by Abeona Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Medical Research
Project
Medical Administration
Abeona Therapeutics News & Media
Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update
- Q2 net ZEVASKYN® revenue increased 31% quarter-over-quarter to $11.4 million –Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
CLEVELAND, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company will host a conference call on Thursday, August 13, 2026 at 8:30 a.m. ET to discuss its financial results for the second quarter of 2026 and provide a corporate update. Abeona will announce its financial results for this period in a press release to be issued prior to the call.CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®
NTAP Designation Expected to Support Medicare Patient Access, Treatment Center Economics and Commercial Adoption NTAP Designation Expected to Support Medicare Patient Access, Treatment Center Economics and Commercial AdoptionAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Abeona Therapeutics
Sign Up For FreeTo access detailed company insights
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on the research, development, manufacturing, and commercialization of advanced cell and gene therapies for serious diseases with significant unmet medical needs. The company is dedicated to developing innovative treatment approaches that address the underlying causes o... Read More
